Abstract
Breast cancer, the most prevalent cancer in women, develops from breast tissue. Its incidence has increased in recent years due to environmental risk factors. Thus, it is urgent to uncover the mechanism underlying breast cancer to design effective treatments. Identification of all breast cancer-related genes is one way to help elucidate the underlying breast cancer mechanism. In this study, a computational method was built and applied to discover new candidate breast cancer-related genes. Based on the known breast cancer-related genes retrieved from public databases, the shortest path algorithm was applied to discover new candidate genes in the protein-protein interaction network. The analysis results of the selected genes suggest that some of them are deemed breast cancer-related genes according to the most recent published literature, while others have direct or indirect associations with the initiation and development of breast cancer.
Keywords: Betweenness, breast cancer, disease gene, protein-protein interaction, shortest path algorithm, weighted network.
Graphical Abstract
Current Bioinformatics
Title:Application of the Shortest Path Algorithm for the Discovery of Breast Cancer-Related Genes
Volume: 11 Issue: 1
Author(s): Lei Chen, Zhi Hao Xing, Tao Huang, Yang Shu, GuoHua Huang and Hai-Peng Li*
Affiliation:
- CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, People’s Republic of China.,China
Keywords: Betweenness, breast cancer, disease gene, protein-protein interaction, shortest path algorithm, weighted network.
Abstract: Breast cancer, the most prevalent cancer in women, develops from breast tissue. Its incidence has increased in recent years due to environmental risk factors. Thus, it is urgent to uncover the mechanism underlying breast cancer to design effective treatments. Identification of all breast cancer-related genes is one way to help elucidate the underlying breast cancer mechanism. In this study, a computational method was built and applied to discover new candidate breast cancer-related genes. Based on the known breast cancer-related genes retrieved from public databases, the shortest path algorithm was applied to discover new candidate genes in the protein-protein interaction network. The analysis results of the selected genes suggest that some of them are deemed breast cancer-related genes according to the most recent published literature, while others have direct or indirect associations with the initiation and development of breast cancer.
Export Options
About this article
Cite this article as:
Chen Lei, Xing Hao Zhi, Huang Tao, Shu Yang, Huang GuoHua and Li Hai-Peng*, Application of the Shortest Path Algorithm for the Discovery of Breast Cancer-Related Genes, Current Bioinformatics 2016; 11 (1) . https://dx.doi.org/10.2174/1574893611666151119220024
DOI https://dx.doi.org/10.2174/1574893611666151119220024 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Point of NO Return for Nitrergic Nerves in Diabetes: A New Insight into Diabetic Complications
Current Pharmaceutical Design Glucans as Biological Response Modifiers
Endocrine, Metabolic & Immune Disorders - Drug Targets Chemoprotective Mechanism of the Natural Compounds, Epigallocatechin- 3-O-Gallate, Quercetin and Curcumin Against Cancer and Cardiovascular Diseases
Current Medicinal Chemistry Versatile Applications of microRNA in Anti-Cancer Drug Discovery: From Therapeutics to Biomarkers
Current Drug Discovery Technologies Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias?
Current Medicinal Chemistry Role of MicroRNAs in the Progression and Metastasis of Colon Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Male Pelvic Pain: Beyond Urology and Chronic Prostatitis
Current Rheumatology Reviews Determination of Dysregulated miRNA Expression Levels by qRT-PCR after the Application of Usnic Acid to Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Medical Image Processing Technology for Diagnosing and Treating Cancers
Recent Patents on Biomedical Engineering (Discontinued) Development of a Simple and Efficient Solution-Phase Parallel Synthesis of Flexible Non-Steroidal Estradiol Mimics
Combinatorial Chemistry & High Throughput Screening Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets Galanthus nivalis Agglutinin (GNA)-Related Lectins: Traditional Proteins, Burgeoning Drugs?
Current Chemical Biology Understanding the Multifaceted Role of Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2) and its Altered Behaviour in Human Diseases
Current Molecular Medicine Augmenting T Helper Cell Immunity in Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Positron Emission Tomography in the Diagnosis and Treatment Management of Tuberculosis
Current Pharmaceutical Design Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line
Current Drug Discovery Technologies Nanocarriers in Improved Heparin Delivery: Recent Updates
Current Pharmaceutical Design Emergence of Functionalized Nanomedicines in Cancer Chemotherapy: Recent Advancements, Current Challenges and Toxicity Considerations
Recent Patents on Nanomedicine Exosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment
Current Gene Therapy The Role of Integrins in Glioma Biology and Anti-Glioma Therapies
Current Pharmaceutical Design